AU5446798A - Compositions and methods for the treatment of gastrointestinal disorders - Google Patents

Compositions and methods for the treatment of gastrointestinal disorders

Info

Publication number
AU5446798A
AU5446798A AU54467/98A AU5446798A AU5446798A AU 5446798 A AU5446798 A AU 5446798A AU 54467/98 A AU54467/98 A AU 54467/98A AU 5446798 A AU5446798 A AU 5446798A AU 5446798 A AU5446798 A AU 5446798A
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
gastrointestinal disorders
gastrointestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54467/98A
Inventor
Sekhar Mitra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU5446798A publication Critical patent/AU5446798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54467/98A 1996-11-27 1997-11-19 Compositions and methods for the treatment of gastrointestinal disorders Abandoned AU5446798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75366196A 1996-11-27 1996-11-27
US08753661 1996-11-27
PCT/US1997/021152 WO1998023272A1 (en) 1996-11-27 1997-11-19 Compositions and methods for the treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
AU5446798A true AU5446798A (en) 1998-06-22

Family

ID=25031613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54467/98A Abandoned AU5446798A (en) 1996-11-27 1997-11-19 Compositions and methods for the treatment of gastrointestinal disorders

Country Status (3)

Country Link
JP (1) JP2001509791A (en)
AU (1) AU5446798A (en)
WO (1) WO1998023272A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600071D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
MXPA04007169A (en) * 2002-01-25 2004-10-29 Santarus Inc Transmucosal delivery of proton pump inhibitors.
JP4749660B2 (en) * 2002-10-16 2011-08-17 武田薬品工業株式会社 Stable solid formulation
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
AR056062A1 (en) 2006-06-05 2007-09-19 Bago Sa Labor ANTI-AGED PHARMACEUTICAL COMPOSITION IN DUST FORM, PHARMACEUTICAL PREPARATION THAT UNDERSTANDS IT AND PROCESS FOR PREPARATION
RU2410100C2 (en) 2009-03-30 2011-01-27 Александр Владимирович Диковский Pharmaceutical composition of proton pump inhibitor and prebiotic for treating gastric and duodenal ulcers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594424B2 (en) * 1986-01-03 1990-03-08 University Of Melbourne, The Gastro-oesophageal reflux composition
US5112813A (en) * 1986-03-07 1992-05-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Process for the preparation of a viscosity-stable antacid composition
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DK179687D0 (en) * 1987-04-08 1987-04-08 Farma Food As PREPARATION
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
IT1251153B (en) * 1991-08-06 1995-05-04 Vectorpharma Int SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION HAVING PROHIBITED GASTRIC RESIDENCE
US5447918A (en) * 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
AU7218194A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-alginate-antacid combinations
JP3710473B2 (en) * 1993-10-12 2005-10-26 三菱ウェルファーマ株式会社 Enteric granule-containing tablets
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders
AUPM695294A0 (en) * 1994-07-20 1994-08-11 Borody, Thomas Julius Improved combination therapy dose unit
WO1996029055A1 (en) * 1995-03-17 1996-09-26 The Boots Company Plc Pectin liquid pharmaceutical compositions
SE9600071D0 (en) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I

Also Published As

Publication number Publication date
JP2001509791A (en) 2001-07-24
WO1998023272A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
EP1143956A3 (en) Compositions and methods for the treatment of anorectal disorders
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU3441197A (en) 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
IL143921A0 (en) Compositions for the treatment and prevention of tumors and tumor-related disorders
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU2113295A (en) Novel compositions and methods for water treatment
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU2058697A (en) Treatment of sleep disorders
AU2821295A (en) Compositions and methods for the treatment of tumors
HUP9904073A3 (en) Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU1556497A (en) Agents for the treatment and prevention of aids
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU2555397A (en) Macrophage stimulating protein for the treatment of gastrointestinal disorders
AU1714697A (en) Method and composition for the treatment of osteoarthritis
AU1697197A (en) Immunoconjugate for the treatment of aids
AU2557895A (en) Composition for treating gastrointestinal disorders